THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA GRANTED PATENT FOR THE USE OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS TO TREAT CANCER
The Trustees of the University of Pennsylvania functions as a premier educational institution that offers undergraduate and graduate courses on […]